Aromatase Inhibitor Drug Class Market To Reach USD$ 6.7 Billion By 2033 Growth Drivers, Forecast & Industry (2026)

Aromatase Inhibitor Drug Class Market To Reach USD$ 6.7 Billion By 2033 Growth Drivers, Forecast & Industry (2026). EINPresswire/ -- Market Size and Growth (2026) According to DataM Intelligence, the ...

Jaguar Health Highlights Sharp Strategic Focus on Rare Intestinal Failure Diseases Fueled by Non-Dilutive Funds from Closing of License Deal for Mytesi

Jaguar has received the initial $16M payment related to the company's recently executed US out-license agreement for ...

Devonian Reports Human Liver-on-a-Chip Data Demonstrating Disease-Relevant Modulation of MASH by Thykamine™, with Dose-Dependent Anti-Fibrotic and Anti-Inflammatory Effects

Devonian Health Group Inc. ("Devonian" or the Company) (TSXV: GSD) (OTCQB: DVHGF) today announced positive results from a follow-up preclinical study evaluating Thykamine™ in a human ...